Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs vs Etanercept in Ankylosing Spondylitis
NCT02809781Phase 3Unknown
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jun 2016
- Primary completion
- Aug 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of mesenchymal stem cells in ankylosing spondylitis (AS), sponsored by Sun Yat-sen Memorial Hospital. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT02809781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02809781.